FORTE BIOSCIENCES INC (FBRX) Stock News

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Mentions: GLYC KPTI INTS SNOA ...

12 Health Care Stocks Moving In Monday's After-Market Session

Mentions: AGL HUM PCRX OGEN ...

Forte Biosciences, Inc. Announces Results and Provides Clinical Update

Forte Biosciences, Inc. to Present at Upcoming Investor Meetings

Forte Biosciences to Host R&D Day December 3, 2024

FBRX Stock Earnings: Forte Biosciences Misses EPS for Q2 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Forte Biosciences (NASDAQ:FBRX) just reported results for the second quarter of...

FBRX Stock Earnings: Forte Biosciences Misses EPS for Q2 2024

FBRX stock results show that Forte Biosciences missed analyst estimates for earnings per share the second quarter of 2024.

FBRX Stock Earnings: Forte Biosciences Reported Results for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Forte Biosciences (NASDAQ:FBRX) just reported results for the first quarter of ...

Forte Biosciences, Inc. Announces Oversubscribed $53 Million Private Placement From Leading Healthcare Institutional Investors to Advance FB102 Across Autoimmune Indications

Forte Biosciences, Inc. Announces Third Quarter 2024 Results and Provides Business Update

FBRX Stock Earnings: Forte Biosciences Reported Results for Q1 2024

Forte Biosciences just reported results for the first quarter of 2024.

FBRX Stock Earnings: Forte Biosciences Reported Results for Q4 2023

Forte Biosciences just reported results for the fourth quarter of 2023.

Forte Biosciences, Inc. Announces Second Quarter 2024 Results and Provides Business Update

Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules

Forte Biosciences, Inc. Announces First Quarter 2024 Results and Provides Business Update

FBRX Stock Earnings: Forte Biosciences Reported Results for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Forte Biosciences (NASDAQ:FBRX) just reported results for the fourth quarter of...

Forte Biosciences, Inc. Announces 2023 Results and Provides Business Update

Forte Biosciences, Inc. Reports Inducement Grant Under Nasdaq Listing Rules

Forte Biosciences, Inc. Announces Third Quarter 2023 Results and Provides Business Update

Forte Biosciences rebuke board challengers, re-elect incumbents (NASDAQ:FBRX)

Despite calls or changes to its board, Forte Biosciences (FBRX) shareholders voted to keep the current slate of directors. Read more here.

ISS and Glass Lewis Recommend Forte Biosciences Stockholders Vote FOR Boardroom Change at the Company’s Upcoming Annual Meeting

Concerned Stockholders of Forte Biosciences and Its Independent Director Candidates Share Key Facts that Reinforce the Need for Urgent Change in the Company’s Boardroom

Concerned Stockholders of Forte Biosciences File Definitive Proxy Statement and Send Letter to Stockholders